Both in Pharmaceuticals
Exicure vs Enveric Biosciences
Over the past year XCUR returned −79.0% and ENVB returned −78.2%; their daily moves had a correlation of -0.21.
XCUR −79.0% ENVB −78.2%Growth of $1, one year, split-adjusted
| Metric | XCUR | ENVB |
|---|---|---|
| Price | $0.9348 | $1.46 |
| Market cap | $6.1M | $6.5M |
| Today | −8.04% | −0.68% |
| 1 month | −21.4% | −1.7% |
| 6 months | −72.2% | −63.0% |
| Year to date | −82.8% | −59.8% |
| 1 year | −79.5% | −79.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $1.7M | $8.3M |
| Dividend yield | — | — |
| Volatility (60d) | 88.3% | 49.7% |
| Short % of float | 1.1% | 1.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).